Hemostasis Today

June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
Jun 3, 2026, 16:08

Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity

Pedro Henrique Las Casas, Professor at Sorbonne University, Professor of Internal Medicine at Federal University of Minas Gerais (UFMG), Hematologist at Grupo Oncoclínicas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers adding:

“Happy to share our latest publication in Cancers with Grigoris Gerotziafas.

Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin

In this study, we explored how anticoagulant agents and quercetin influence cancer cell procoagulant activity, thrombin generation, and endothelial dysfunction induced by cancer-derived extracellular vesicles.

Our findings provide new insights into the complex interactions between cancer, thrombosis, and the vascular microenvironment.

I am grateful to my colleagues and collaborators for their valuable contributions, and especially proud to be part of the Cancer–Angiogenesis–Thrombosis and Hemostasis (CaVITE) research team at the CRSA PARIS, Inserm Paris UMR_S_938, Sorbonne Université.

Many thanks to all co-authors and collaborators who made this work possible.”

Title: Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin

Authors: Mohammed A. Baghdadi, Pedro Henrique Fernandes do Carmo Las Casas, Elisabeth Mbemba, Aurélie Rousseau, Prakasha Kempaiah, Andrey A. Svistunov, Victoria Bitsadze, Michèle Sabbah, Jawed Fareed, Patrick Van Dreden, Varvara Trachana, Eleftheria Lefkou, Grigoris Gerotziafas

Pedro Henrique Las Casas

Stay updated on all scientific advances with Hemostasis Today.